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Introduction
We and others have previously shown that patients with
Familial Mediterranean Fever (FMF) had low cholesterol
levels when compared to healthy controls [1,2]. This
was initially brought up by Ozkan E [3]. The causes of this
abnormality are not understood. It could be due to an
inherent effect of FMF or due to a lipid lowering effect of
colchicine, as the patients in these studies were all regular
users. Additionally, earlier studies had suggested that
colchicine may have hypocholesterolemic effect.
Objectives
We conducted a 12 week study to determine whether
colchicine would decrease serum lipid levels in patients
with FMF and Behçet’s syndrome (BS). Lipid levels were
measured in each patient before and after colchicine use.
Methods
Blood cholesterol and triglycerides levels were measured
in 24 patients with FMF (11 M, 13 F) and 16 (8 M, 8 F)
patients with BS who were registered at the outpatient
clinic of Cerrahpasa Medical Faculty. All patients were
naive to colchicine or immunosuppressive treatment or
any other lipid lowering drugs at study entry. Blood
cholesterol and triglycerides levels were measured again
after 12 weeks of colchicine 1.5 mg daily. Colchicine
was withdrawn in one patient with FMF because of liver
toxicity and in another because of nausea. Two patients
with FMF did not use colchicine and another with FMF
was lost to follow-up. Colchicine was switched to
azathioprine in 1 patient with BS because of active disease.
Only patients who completed 12 weeks period were
analyzed.
Results
There were 19 (8 M, 11 F) patients with FMF and 15
(7 M, 8 F) patients with BS who completed the 12 week
period. Patients with FMF were (mean age: 33.8±14.1
years) significantly younger than BS patients (mean age:
36.5±9.5) (P = 0.001). Colchicine did not change choles-
terol and triglycerides levels in patients with FMF
(T.Cholesterol: 169±77 vs 181±48 mg/dl, P = 0.58, Tri-
glycerides: 122±82 vs128±70 mg/dl, P= 0.75, LDL:120
±44 vs 112±40, P=0.35, HDL: 42±13 vs 47±11 mg/dl,
P=0.1, before and after colchicine use, respectively). This
was also true for BS patients (T.cholesterol:181±51 vs
172±44 mg/dl, P=0.53, triglycerides:112±63 vs 107±52
mg/dl, P=0.18, LDL:115±38 vs 106±40 mg/dl, P = 0.85,
HDL:48±9 vs 48.3±9.9 mg/dl, P= 0.3).
Conclusion
This study provided no evidence that colchicine use
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